Kamada KMDA 深 沪
等待开盘 09-03 09:30:00 美东时间
7.02
+0.100
+1.45%
华盛通- 最 高7.0882
- 今 开7.01
- 成交量 7.29万股
- 最 低 6.92
- 昨 收 6.92
- 总市值 4.04亿
- 52周最高 8.955
- 市盈率 静 28.07
- 换手率 0.13%
- 52周最低 4.97
- 委 比 68.87%
- 总股本 5750.50万
- 历史最高 17.75
- 量 比 2.11
- 振 幅 2.43%
- 历史最低 2.82
- 每 手 1
- 风险率 0.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kamada Ltd. Engages Investors at September Conferences
An update from Kamada ( ($IL:KMDA) ) is now available. On September 2, 2025, Ka...
09-02 19:28
Kamada to Participate in Upcoming September Investor Conferences
Kamada Ltd., a global biopharmaceutical company specializing in rare and serious conditions, announced that Amir London, its CEO, will present at two major conferences: the 2025 Wells Fargo Healthcare Conference on September 3, 2025, and the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. Both events include investor meetings and live webcasts for attendees. Kamada focuses on four strategic pillars: organic growth, ...
09-02 11:00
Kamada Affirms FY2025 Sales Guidance of $178.000M-$182.000M vs $180.697M Est
Fiscal 2025 GuidanceKamada is increasing its adjusted EBITDA guidance from a range of $38 million to $42 million to a range of $40 million to $44 million and continues to expect to generate fiscal year 2025 total
08-13 19:04
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
An Overview of Kamada's Earnings
Kamada (NASDAQ:KMDA) is set to give its latest quarterly earnings report on Wed...
08-13 00:01
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
Kamada Ltd. announced FDA approval for its Houston plasma collection center, allowing commercial sales of normal source plasma. The state-of-the-art facility can collect approximately 50,000 liters annually, contributing $8-10 million in revenue. It is expected to be one of the largest specialty plasma collection sites in the U.S. The company also operates centers in San Antonio and Beaumont, Texas, and plans to seek EMA approval for the Houston ...
08-11 11:00
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025
Kamada Ltd. announced it will release second-quarter and first-half 2025 financial results on August 13, 2025, prior to U.S. market open. Management will host an investor conference call at 8:30am ET the same day to discuss results and answer questions. The call can be accessed via phone or webcast. Kamada is a global biopharmaceutical company focused on rare and serious conditions, with a strong portfolio of plasma-derived products and a strateg...
08-06 11:00
日本执政党或失去参议院多数！最新民调揭露巨大政治风险
①日本参议院选举在即，但据民调显示，执政联盟自民党和公明党可能失去多数席位，引发政治风险； ②选民对通货膨胀和自民党丑闻不满，而若执政联盟失势，可能引发首相石破茂辞职呼声； ③专家指出，执政党在众议院和参议院都只占少数是日本自二战以来从未经历过的局面，日本政坛前景不明。
07-16 15:23
CORRECTION: Kamada Reported Business Operations on June 17, 2025.
CORRECTION: Kamada Reported Business Operations on June 17, 2025.
06-25 03:34
Kamada Assures Uninterrupted Drug Supply as Israeli Operations Continue Despite Middle East Tensions
Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA))), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today
06-17 19:04
